Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HIV virology for clinical trials.
Shafer RW, Merigan TC. Shafer RW, et al. AIDS. 1995;9 Suppl A:S193-202. AIDS. 1995. PMID: 8819586 Review. No abstract available.
Predictors of survival in HIV-infected tuberculosis patients.
Shafer RW, Bloch AB, Larkin C, Vasudavan V, Seligman S, Dehovitz JD, DiFerdinando G, Stoneburner R, Cauthen G. Shafer RW, et al. AIDS. 1996 Mar;10(3):269-72. doi: 10.1097/00002030-199603000-00005. AIDS. 1996. PMID: 8882666
ACTG 260: a randomized, phase I-II, dose-ranging trial of the anti-human immunodeficiency virus activity of delavirdine monotherapy. The AIDS Clinical Trials Group Protocol 260 Team.
Para MF, Meehan P, Holden-Wiltse J, Fischl M, Morse G, Shafer R, Demeter LM, Wood K, Nevin T, Virani-Ketter N, Freimuth WW. Para MF, et al. Antimicrob Agents Chemother. 1999 Jun;43(6):1373-8. doi: 10.1128/AAC.43.6.1373. Antimicrob Agents Chemother. 1999. PMID: 10348755 Free PMC article. Clinical Trial.
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260).
Demeter LM, Shafer RW, Meehan PM, Holden-Wiltse J, Fischl MA, Freimuth WW, Para MF, Reichman RC. Demeter LM, et al. Among authors: shafer rw. Antimicrob Agents Chemother. 2000 Mar;44(3):794-7. doi: 10.1128/AAC.44.3.794-797.2000. Antimicrob Agents Chemother. 2000. PMID: 10681363 Free PMC article. Clinical Trial.
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients.
Shulman NS, Hughes MD, Winters MA, Shafer RW, Zolopa AR, Hellmann NS, Bates M, Whitcomb JM, Katzenstein DA. Shulman NS, et al. Among authors: shafer rw. J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):121-7. doi: 10.1097/00126334-200210010-00001. J Acquir Immune Defic Syndr. 2002. PMID: 12394789 Clinical Trial.
297 results